The Marin Independent Journal picked up an article published in Cureus about cohesive mitigation school strategies as protective factors against the increase of COVID-19 cases.
COVID-19 infections declined in Marin as schools in the county reopened for in-person learning last year, according to a new study.
The study, published last month in the peer-reviewed national medical journal Cureus, tracked attendance at 77 transitional kindergarten through eighth-grade Marin schools from Sept. 8, 2020, to Jan. 21.
Researchers found a correlation between having more students in class in person and lower COVID-19 rates in the community. That was in contrast to school breaks — such as Halloween and holiday time off in December — when cases spiked, said study co-author Dr. Michaela George, an epidemiologist and assistant professor at Dominican University of California in San Rafael.
“It shows that when schools follow the advice of their local public health officials and there is a good collaboration with local educators, kids can stay safe in the classroom,” George said…
Read the full article from the Marin Independent Journalhere. Read the Cureus article here.
Alexander Muacevic is the Medical Director of the European Cyberknife Center in Munich, Germany and holds an academic teaching position at the University of Munich Hospitals. Dr. Muacevic is a board-certified neurosurgeon and radiosurgeon and his main clinical and scientific interest is full body radiosurgery using advanced image-guided robotic technology. In addition to earning a European Neurosurgery Certificate, Dr. Muacevic has published over 100 scientific contributions including peer-reviewed articles, book chapters and congress proceedings. Dr. Muacevic is also a member of several academic societies and president of the International Radiosurgery Society containing over 700 members. Last, but not least, Dr. Muacevic is the Co-Founder and Co-Editor-in-Chief of the Cureus Journal of Medical Science.
Q: What was your first publishing experience like?
A: I started with smaller retrospective studies around Gamma Knife radiosurgery and I remember it was tough as a junior resident to fulfill all of the scientific standards.
Q: How did your relationship with Dr. John Adler begin?
A: We knew each other from neurosurgery meetings but got to work more closely together via the Radiosurgery Society and finally when we started our Cyberknife center in Munich in 2005.
Q: Has open science always been something you’ve been passionate about?
A: No, this developed over time and was based on frustrations in the conventional publishing world with more and more bureaucratic hurdles.
Q: In your opinion, what are the greatest challenges facing Open Access publishing?
A: Getting wide spread acceptance in the academic world.
Q: Is there anything about Cureus that you are particularly proud of?
A: Of course! We started from scratch over 10 years ago with only four people working to publish one article a month and now we have a much larger team and are publishing close to 10,000 articles this year. A great team effort and achievement!
Q: Do you have any advice for first-time authors?
A: Take your time, try to be precise and correct, and learn from more experienced people. Perhaps a simple case report with Cureus is the ideal introduction to the academic world.
Q: What are you looking for from Cureus peer reviewers?
A: A clear, concise and unbiased analysis of the paper in question.
Q: What is it like having Dr. Adler as a partner?
A: He is the best partner to have, as he is always open to strong arguments. I enjoy the fair battles we have behind the curtain to make Cureus a better journal each and every day.
Q: Why should researchers submit to Cureus?
A: Because it is the best and fastest way to get peer reviewed science out to the world. I might be biased but I don’t know any journal which is more comfortable and also fun to publish with.
Q: Are you currently working on any research? If so, what can you tell us about it?
A: We are working on multiple projects like SRS for Trigeminal Neuralgia, Meningiomas and Renal Cell Cancer.
The Cureus Blog 